117
and cosmetic limitations for surgeons owing to positive surgical
margins and increased locoregional recurrence rates.
Objective:
The aim of this retrospective case series is to eval-
uate the outcomes of patients diagnosed and treated for Merkel
cell carcinoma at the University of Florida, College of Medicine
Jacksonville.
Methods:
Patients treated for Merkel cell carcinoma were iden-
tified through retrospective chart review from January 2009 to
September 2016. Patient demographics, tumour site, comorbidi-
ties, presence of positive margins, and treatment modalities were
correlated with outcomes. Survival rates were calculated using the
Kaplan-Meier method.
Findings and Conclusion:
A total of seven patients were iden-
tified during this time period. Overall survival rate was 85.71%.
The mean age was 76 years at time of initial treatment. 57% of
patients experienced recurrent disease with a mean time to recur-
rence of 379.6 days. There was no significant association between
disease-free survival time and age. While there was no correlation
in this series with positive margins and those with recurrence, a
larger prospective series may prove otherwise.
http://dx.doi.org/10.1016/j.ijom.2017.02.410Maxilla carcinoma and occult neck metastases: implications
for management of the clinically node negative neck
E.V. Cann
∗
, M. Joosten, R. de Bree
Department of Head and Neck Surgical Oncology, UMC Utrecht
Cancer Center, University Medical Center Utrecht, The
Netherlands
Background:
The management of the clinically node negative
(N0) neck in patients with squamous cell carcinoma of the maxilla
(MSCC) is a matter of debate. In this retrospective cohort study the
incidence, survival of, and factors associated with occult metas-
tases was determined in patients with MSCC and clinically N0
neck.
Objective:
To evaluate the management of the clinically N0 neck
in MSCC.
Methods:
77 consecutive patients with MSCC and a ‘watch and
wait’ strategy for the clinically N0 neck were included. Clinical
and histopathological data were gathered from the patient records.
The incidence of occult metastases was calculated. Survival was
calculated using Kaplan-Meier survival analysis. Cox regression
analysis was used to assess the predictive value of the clinical and
histopathological parameters.
Findings:
Occult metastases occurred in 14.3% (11/77). Patients
with T4 showed the highest rate of occult metastases (24.1%).
45% (5/11) of the metastases were located in the contralateral neck
while the MSCCs did not cross the midline in these five patients.
Five year overall survival was 62.3% and five year disease-specific
survival was 87.0%. The hazard ratio for perineural growth was
5.39 (
P
= 0.017) and for perivascular invasion 11.12 (
P
= 0.003).
Conclusion:
Patients with T4 MSCC and clinically N0 neck
showed a high rate of occult neck metastases. For these patients we
recommend elective treatment of the neck. Sentinel node biopsy
may improve the detection of occult metastases in the ipsilateral
and contralateral neck while avoiding the drawbacks of bilateral
elective neck dissection or radiotherapy.
http://dx.doi.org/10.1016/j.ijom.2017.02.411Proposal of preoperative nutrition index predict survival of
elderly patients with oral cancer: the cumulative effect of
preoperative anaemia, serum albumen and body mass index
influences clinical outcome irrespective of comorbidity
W. Cao
∗
, Z. Liu, C.B. Peng, R. Yang, C.Z. Lin, Z.H. Ren, T. Ji
Department of Oral Maxillofacial-Head and Neck Oncology,
Ninth People’s Hospital, Shanghai Jiao Tong University School
of Medicine, China
Background:
The risk factors for elderly oral cancer patients’
survival are multifarious.
Objectives:
We developed a novel nutrition index to predict prog-
nosis of these patients.
Methods:
The data of patients with oral cancer (age >60 years)
treated was collected. Clinicopathological parameters and the
nutrition index along with comorbidity indexes were analysed
for overall survival (OS), disease free survival (DFS) and disease
specific survival (DSS).
Findings:
Patients with age
≥
75 years, palate site, recurrent
tumours, advanced pathological T, pathological N positive, severe
tumour grade, preoperative anaemia, low serum albumen and low
BMI along with high-risk nutrition index instead of the comorbid-
ity indexes, showed poorer OS, DFS and DSS. Multivariate Cox
analysis showed the nutrition index was an independent indicator
for OS (
P
< 0.001), DFS (
P
< 0.001) and DSS (
P
< 0.001).
Conclusion:
We developed a novel nutrition index as an indepen-
dent predictor for prognosis of elderly oral cancer patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.412Ossifying fibroma of the maxilla: case report and review of
the literature
D. Cebreros
∗
, O. García, A. Sada, M.E. Iglesias, L. Miragall,
M. Puche
Department of Oral and Maxillofacial Surgery, Hospital Clínico
Universitario, Valencia, Spain
Background:
Ossifying fibroma is a benign fibro-osseous lesion.
The aetiology is still unknown. It tends to arise from the mes-
enchymal blast cells of the periodontal ligament. It presents as
a progressively growing lesion, between 3rd and 4th decades
of life with a female predilection, and can attain an enormous
size with resultant deformity if left untreated. Radiologically, it
shows features of radiolucency, mixed radiolucency and opacity
and complete radiopacity depending on the degree of mineralisa-
tion. Management includes curettage or enucleation or resection
of the lesion depending on the stage and extent.
Clinical case:
A 45-year-old woman was referred to our depart-
ment with a slow increasing mass in the left maxilla that provoke
loosening of the second molar. We describe the history, diagnosis,
radiologic studies and the treatment outcome.
Conclusions:
This entity is one of the differential diagnosis that
needs to be considered when a slow increasing mass appears in
the facial skeleton. The differential diagnosis having radiopacities
within a well-defined radiolucent mass includes chondrosarcoma,
osteosarcoma, fibrous dysplasia, squamous cell carcinomas, cal-
cifying odontogenic cysts, and calcifying epithelial odontogenic
tumours. The well-defined border of the ossifying fibroma helps
differentiate it from the aggressive sarcomas and carcinomas.




